The serum VEGF-D levels of these untreated S-LAM (n = 88) and TSC-LAM (n = 10) patients were remarkably stable throughout the study (Fig 5A), and whether the patients were pre- (Fig 5B) or post-menopausal (Fig 5C). The gene discussed is VEGFD; the disease is tuberous sclerosis.